Back
Innate Pharma SA Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
IPHA
Innate Pharma SA
Last Price:
$1.37
Seasonality Move:
-5.63%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IPHA is experiencing slight buying pressure.
Innate Pharma SA Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.29 | Buy |
| 20-day SMA: | 1.38 | Sell |
| 50-day SMA: | 1.58 | Sell |
| 200-day SMA: | 1.86 | Sell |
| 8-day EMA: | 1.29 | Buy |
| 20-day EMA: | 1.05 | Buy |
| 50-day EMA: | 0.62 | Buy |
| 200-day EMA: | 0.2 | Buy |
Innate Pharma SA Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 45.85 | Sell |
| Chaikin Money Flow: | 2443 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.27 - 1.59) | Sell |
| Bollinger Bands (100): | (1.51 - 1.91) | Sell |
Innate Pharma SA Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Innate Pharma SA Stock
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 1.37 while IPHA 8-day simple moving average is 1.29, which is a Buy signal.
-
The stock price of IPHA is 1.37 while Innate Pharma SA 20-day SMA is 1.38, which makes it a Sell.
-
Innate Pharma SA 50-day simple moving average is 1.58 while IPHA share price is 1.37, making it a Sell technically.
-
IPHA stock price is 1.37 and Innate Pharma SA 200-day simple moving average is 1.86, creating a Sell signal.
IPHA Technical Analysis vs Fundamental Analysis
Sell
38
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy or a Sell?
-
Innate Pharma SA stock is rated a SellThe current Innate Pharma SA [IPHA] share price is $1.37. The Score for IPHA is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Innate Pharma SA Stock Info
Market Cap:
130.3M
Price in USD:
1.37
Share Volume:
17.3K
Innate Pharma SA 52-Week Range
52-Week High:
2.63
52-Week Low:
1.17
Sell
38
Innate Pharma SA (IPHA)
is a Sell
Innate Pharma SA Share Price Forecast
-
What is the Innate Pharma SA stock price today?The Innate Pharma SA stock price is 1.37 USD today.
-
Will IPHA stock go up or go down?Innate Pharma SA> share price is forecast to RISE/FALL based on technical indicators
-
Is Innate Pharma SA overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innate Pharma SA is overvalued.
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 1.37 while IPHA 8-day exponential moving average is 1.29, which is a Buy signal.
-
The stock price of IPHA is 1.37 while Innate Pharma SA 20-day EMA is 1.05, which makes it a Buy.
-
Innate Pharma SA 50-day exponential moving average is 0.62 while IPHA share price is 1.37, making it a Buy technically.
-
IPHA stock price is 1.37 and Innate Pharma SA 200-day simple moving average is 0.20, creating a Buy signal.
Fundamental Analysis of Innate Pharma SA
Is Innate Pharma SA a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.13 per share.
Technical Analysis of Innate Pharma SA
Should I short Innate Pharma SA stock?
-
IPHA Moving Average Covergence Divergence (MACD) indicator is 0.29, suggesting Innate Pharma SA is a Buy
-
Innate Pharma SA Relative Strength Index (RSI) is 45.85, which suggest Innate Pharma SA is oversold
-
The Bollinger Bands (25) for Innate Pharma SA is (1.27 - 1.59), which suggest Innate Pharma SA is a Sell
-
The Bollinger Bands (100) for Innate Pharma SA is (1.51 - 1.91), which suggest Innate Pharma SA is a Sell
* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.